Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2942020 | JACC: Cardiovascular Interventions | 2009 | 9 Pages |
Abstract
This large, international multicenter registry provides important information regarding the long-term safety and efficacy of the Endeavor ZES across standard and extended-use patients in the real-world setting. Rates of MACE and measures of safety including cardiac death, myocardial infarction, and stent thrombosis were low and consistent with pooled results of clinical trials. (E-Five Registry: A World-Wide Registry With The Endeavor Zotarolimus Eluting Coronary Stent [eFive Registry]; NCT00623441)
Keywords
multicenter registryPESzotarolimus-eluting stent(s)CECTLRBMSTVFPCIMACECK-MBtarget lesion revascularizationSESMyocardial infarctionDESdrug-eluting stent(s)paclitaxel-eluting stent(s)bare-metal stent(s)sirolimus-eluting stent(s)drug-eluting stentStent thrombosisrestenosismajor adverse cardiac eventsZEStarget vessel failureCoronary artery lesionTarget vessel revascularizationArcpercutaneous coronary interventionTVRclinical events committeeAcademic Research Consortiumcreatine kinase-myocardial band
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Chaim MD, Ian T. MBBS, PhD, Laura MD, MSc, Minglei PhD, Martin T. MB, ChB, E-Five Investigators E-Five Investigators,